OXYCODONE AND ASPIRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxycodone And Aspirin, and when can generic versions of Oxycodone And Aspirin launch?
Oxycodone And Aspirin is a drug marketed by Actavis Labs Fl Inc, Ani Pharms, Dr Reddys Labs Sa, Epic Pharma Llc, Sun Pharm Industries, and Roxane. and is included in seven NDAs.
The generic ingredient in OXYCODONE AND ASPIRIN is aspirin; oxycodone hydrochloride; oxycodone terephthalate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; oxycodone hydrochloride; oxycodone terephthalate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXYCODONE AND ASPIRIN?
- What are the global sales for OXYCODONE AND ASPIRIN?
- What is Average Wholesale Price for OXYCODONE AND ASPIRIN?
Summary for OXYCODONE AND ASPIRIN
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 7 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 6 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OXYCODONE AND ASPIRIN at DailyMed |
![OXYCODONE AND ASPIRIN drug patent expirations Drug patent expirations by year for OXYCODONE AND ASPIRIN](/p/graph/s/t/OXYCODONE_AND_ASPIRIN-patent-expirations.png)
Recent Clinical Trials for OXYCODONE AND ASPIRIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of North Carolina, Chapel Hill | Phase 4 |
Albany Medical College | Phase 4 |
John Mascarenhas | Phase 1 |
Pharmacology for OXYCODONE AND ASPIRIN
Drug Class | Nonsteroidal Anti-inflammatory Drug Opioid Agonist Platelet Aggregation Inhibitor |
Mechanism of Action | Cyclooxygenase Inhibitors Full Opioid Agonists |
Physiological Effect | Decreased Platelet Aggregation Decreased Prostaglandin Production |